Oramed Pharmaceuticals
ORMP
ORMP
56 hedge funds and large institutions have $18.6M invested in Oramed Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 17 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 55 → 56 (+1)
17% less call options, than puts
Call options by funds: $44K | Put options by funds: $53K
18% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 17
Holders
56
Holding in Top 10
2
Calls
$44K
Puts
$53K
Top Buyers
| 1 | +$1.11M | |
| 2 | +$205K | |
| 3 | +$197K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$170K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$124K |
Top Sellers
| 1 | -$226K | |
| 2 | -$105K | |
| 3 | -$75.8K | |
| 4 |
Squarepoint
New York
|
-$70K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$60.3K |